S
MIRM icon

SignatureFD’s Mirum Pharmaceuticals MIRM Stock Holding History

SignatureFD’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.9K Hold
170
– – ﹤0.01% 2350
2026
Q1 		$15.7K Sell
170
-8
-4% -$753 ﹤0.01% 2314
2025
Q4 		$14.1K Sell
178
-12
-6% -$861 ﹤0.01% 2269
2025
Q3 		$13.9K Buy
190
+10
+6% +$636 ﹤0.01% 2273
2025
Q2 		$9.16K Sell
180
-35
-16% -$1.56K ﹤0.01% 2381
2025
Q1 		$9.69K Hold
215
– – ﹤0.01% 2371
2024
Q4 		$8.89K Sell
215
-6
-3% -$250 ﹤0.01% 2408
2024
Q3 		$8.62K Buy
221
+41
+23% +$1.64K ﹤0.01% 2386
2024
Q2 		$6.15K Buy
180
+10
+6% +$262 ﹤0.01% 2445
2024
Q1 		$4.27K Sell
170
-4
-2% -$110 ﹤0.01% 2586
2023
Q4 		$5.14K Buy
174
+4
+2% +$121 ﹤0.01% 2486
2023
Q3 		$5.37K Hold
170
– – ﹤0.01% 2463
2023
Q2 		$4.4K Sell
170
-5
-3% -$133 ﹤0.01% 2553
2023
Q1 		$4.2K Buy
175
+152
+661% +$3.46K ﹤0.01% 2577
2022
Q4 		$449 Buy
+23
New +$455 ﹤0.01% 3119

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SignatureFD's MIRM Position: Q2 2026 in Review

SignatureFD held its Mirum Pharmaceuticals (MIRM) position steady in Q2 2026 at 170 shares worth $19.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2350.

SignatureFD first reported a position in MIRM in Q4 2022 and has held it in 15 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • SignatureFD held 170 shares of Mirum Pharmaceuticals worth $19.9K as of Q2 2026.
  • SignatureFD left its Mirum Pharmaceuticals share count unchanged in Q2 2026.
  • Mirum Pharmaceuticals made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #2350 holding.
  • SignatureFD first reported a position in Mirum Pharmaceuticals in Q4 2022 and has held it in 15 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.